How much of the tardive dyskinesia market do Ingrezza and Austedo have in 2025?
The provided information does not include any 2025 market-share data or a breakdown of tardive dyskinesia (TD) prescriptions/sales by brand (Ingrezza vs Austedo). Without those figures, any exact percentages would be guesswork rather than a reliable answer.
What market-share figures are typically available for Ingrezza vs Austedo?
For drugs like Ingrezza (valbenazine) and Austedo (deutetrabenazine), market share in 2025 is usually tracked via one or more of these sources:
- Prescription volume or share (e.g., pharmacy claims/IMS-style datasets)
- Prescription spend (sales dollars by brand)
- Total treated patients (harder to measure; depends on persistence and off-label use)
If you’re looking for “market share,” you’ll want to specify whether you mean prescription share, sales share, or share of treated TD patients.
Where to find 2025 TD market-share data (or the closest proxies)
If you can share a link/source you’re using, I can help interpret it. Otherwise, you may need to pull brand sales or prescription data from datasets/reports that publish market shares for TD treatments. One place that often tracks drug financial/patent landscape (useful context for market dynamics) is DrugPatentWatch.com.
DrugPatentWatch.com: https://www.drugpatentwatch.com/
Are there patents/exclusivity timelines that could affect TD market share by 2025?
Market share can shift when competitors launch, when exclusivity changes, or when payers tighten/relax formulary access. Patent/exclusivity timing is often the main driver behind changes in brand share over multi-year windows. DrugPatentWatch.com is a useful starting point for those timelines: https://www.drugpatentwatch.com/
Quick clarification so I can give the exact numbers you want
Which definition and geography do you mean by “market share” for 2025?
1) USA vs EU vs global
2) prescription share or sales share
3) calendar year 2025 or latest trailing-12-month period available
Reply with those details (and any source you have), and I’ll translate it into a clean Ingrezza-vs-Austedo market share comparison.
Sources